TGR Scientist wins the bioinnovation SA young achiever award

TGR is delighted to announce that Dr Antony Sheehan, Principal Scientist at TGR, has been awarded the prestigious 2012 BioSA Young Achiever award. The award was presented to Dr Antony Sheehan by the Minister for Science and Information Economy, the Hon Grace Portolesi, MP, at the AusBiotech Business Development Workshop and Forum Welcome Reception on March 2019.

The award recognises Dr Sheehan’s contribution to TGR’s scientific development, commercial strategy, and his leadership skills.

Dr Sheehan joined TGR BioSciences in 2007, initially appointed as a senior scientist. Since joining TGR, Dr Sheehan has played a key role in the development of TGR’s CaptSure™ sandwich immunoassay platform which is attracting major international attention, and currently leads the R&D and product development teams.

Dr Sheehan plays a key role in aligning TGR’s technical workplans with its commercial goals and is committed to driving innovation in the research sector, particularly in the field of protein detection technologies.

For more information, contact;

Anne Hinton, CEO

ahinton@tgrbio.com, +61 8 8354 6174

TGR announce completion of ownership restructure

TGR BioSciences wishes to announce the transaction to facilitate the exit of the Nanyang Innovation Fund and Statewide Superannuation has been completed. The early investment by these shareholders was essential in assisting the Company to develop its current technologies.  The Company is pleased that Management and other current shareholders were able to fund the exit transaction confirming their commitment to the Company’s business strategy.

TGR would like to recognise the substantial contribution and support given by all of its exiting shareholders. Further, the significant commitment by departing Directors John Bastian (Independent) and Simon Uzcilas (Nanyang) greatly assisted in completion of the transaction.

TGR BioSciences is a private company located in Adelaide, Australia. Established in 2001, TGR is committed to providing innovative solutions for cell-based research applications. Our scientists have expertise in cell biology, biochemistry and immunoassay design, and have developed products and services of the highest quality, which have been used successfully in drug discovery programs around the world.

For more information, contact;

Anne Hinton, CEO, TGR BioSciences

ahinton@tgrbio.com, +61 8 8354 6174

or

Andrew Sneddon, Chairman, TGR BioSciences

asneddon@tgrbio.com